Back
Top 5%
14.5%
#1
14.5%
Top 2%
11.7%
Top 2%
7.7%
Top 2%
7.7%
Top 77%
5.9%
Top 4%
3.8%
Top 2%
3.0%
Top 2%
2.8%
Top 81%
1.9%
Top 9%
1.9%
Top 6%
1.9%
Top 3%
1.9%
Top 2%
1.5%
Top 7%
1.3%
Top 1.0%
1.2%
Top 5%
0.9%
Top 67%
0.7%
Top 10%
0.7%
Top 18%
0.7%
Top 2%
0.7%
Top 8%
0.7%
Identification of Conserved Immune-Related Adverse Event Risk Factors and Clinical Outcomes in a Pan-Immunotherapy Data Mart
2025-06-06
oncology
Title + abstract only
View on medRxiv
Show abstract
BackgroundCancer immunotherapy often triggers immune-related adverse events (irAEs). Analysis of irAEs in large checkpoint inhibitor (CPI) trials has enhanced their management and demonstrated their prognostic value for treatment outcome. However, data on irAEs in non-standard cancer immunotherapies (CITs) are limited, and systematic exploration is lacking. Identifying predictive biomarkers for irAEs in these therapies is still emerging and essential for improving patient care. MethodsWe establ...
Predicted journal destinations
1
Nature Communications
483 training papers
2
Clinical Cancer Research
22 training papers
3
Cancers
57 training papers
4
eLife
262 training papers
5
Frontiers in Oncology
34 training papers
6
PLOS ONE
1737 training papers
7
Frontiers in Immunology
140 training papers
8
Cancer Medicine
17 training papers
9
British Journal of Cancer
22 training papers
10
Scientific Reports
701 training papers
11
JAMA Network Open
125 training papers
12
Proceedings of the National Academy of Sciences
100 training papers
13
BMC Cancer
21 training papers
14
Journal of Clinical Investigation
50 training papers
15
iScience
74 training papers
16
Cell Reports
25 training papers
17
Cell Reports Medicine
49 training papers
18
BMJ Open
553 training papers
19
Nature
58 training papers
20
Nature Medicine
88 training papers
21
International Journal of Cancer
18 training papers
22
Communications Medicine
63 training papers